Inventor · disambiguated record
Osamu Honmou
Also filed as: HONMOU OSAMU
12 granted patents·19 pending applications·23 citations·filing 2002–2023
87Inventor score
Top patents by PatentIndex Score
31 records- 0189US7968088B2Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredientHONMOU OSAMU·Filed 2008·Granted Jun 28, 2011·8 cites·3 claims
- 0279US10328102B2Cell growth method and pharmaceutical preparation for tissue repair and regenerationUNIV SAPPORO MEDICAL·Filed 2017·Granted Jun 25, 2019·2 cites·20 claims
- 0377US11426432B2Cell growth method and pharmaceutical preparation for tissue repair and regenerationUNIV SAPPORO MEDICAL·Filed 2019·Granted Aug 30, 2022·0 cites·9 claims
- 0474US9700582B2Cell growth method and pharmaceutical preparation for tissue repair and regenerationHONMOU OSAMU·Filed 2008·Granted Jul 11, 2017·3 cites·5 claims
- 0573US9115344B2Mesenchymal stem cell and a method of use thereofHONMOU OSAMU·Filed 2012·Granted Aug 25, 2015·2 cites·8 claims
- 0673US7098027B2Method for remyelinating a demyelinized lesion due to injury in the brain or spinal cordHITACHI LTD·Filed 2002·Granted Aug 29, 2006·7 cites·2 claims
- 0764US2024122988A1Synapse formation agentUNIV SAPPORO MEDICAL·Filed 2023·Application pending·0 cites
- 0861US2009280564A1Method for inducing differentiation of mesodermal stem cells, es cells, or immortalized mesodermal stem cells into neural cellsHITACHI LTD·Filed 2009·Application pending·0 cites
- 0961US2006210544A1Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredientHITACHI LTD·Filed 2006·Application pending·0 cites
- 1061US2008248004A1Cell fractions containing cells capable of differentiating into neural cellsHITACHI LTD·Filed 2008·Application pending·0 cites
- 1156US10563173B2Autoserum-containing bone marrow cell culture system, autoserum-containing bone marrow cell culture method, and method for producing medicinal composition comprising autoserum-containing cultured bone marrow cells as active ingredientUNIV SAPPORO MEDICAL·Filed 2017·Granted Feb 18, 2020·0 cites·10 claims
- 1256US2013195808A1Mesenchymal stem cell and a method of use thereofHONMOU OSAMU·Filed 2013·Application pending·0 cites
- 1354US2005282276A1Cell fractions containing cells capable of differentiating into neural cellsHITACHI LTD·Filed 2005·Application pending·0 cites
- 1453US11666601B2Synapse formation agentUNIV SAPPORO MEDICAL·Filed 2017·Granted Jun 6, 2023·0 cites·11 claims
- 1553US10640749B2Mesenchymal stem cell and the method of use thereofNC MEDICAL RES INC·Filed 2015·Granted May 5, 2020·0 cites·14 claims
- 1653US2004259254A1Method for inducing differentiation mesodermal stem cells, es cells or immortalized cells into nervous system cellsHONMOU OSAMU·Filed 2002·Application pending·0 cites
- 1752US2007178591A1Internally administered therapeutic agents for diseases in central and peripheral nervous system comprising mesenchymal cells as an active ingredientHITACHI LTD·Filed 2004·Application pending·0 cites
- 1850US2023193206A1Method for Producing Serum for Culturing Mammalian CellsUNIV SAPPORO MEDICAL·Filed 2020·Application pending·0 cites
- 1950US2011158967A1Mesenchymal stem cell and the method of use thereofNC MEDICAL RES INC 75 INTEREST·Filed 2011·Application pending·0 cites
- 2043US9683214B2Autoserum-containing bone marrow cell culture system, autoserum-containing bone marrow cell culture method, and method for producing medicinal composition comprising autoserum-containing cultured bone marrow cells as active ingredientHONMOU OSAMU·Filed 2011·Granted Jun 20, 2017·0 cites·7 claims
- 2143US2005084959A1Immortalized mesenchymal cells and utilization thereofFiled 2002·Application pending·0 cites
- 2242US2020345781A1Medicine for tissue regeneration, and preparation method thereforUNIV SAPPORO MEDICAL·Filed 2018·Application pending·0 cites
- 2341US2006062771A1Therapeutic autologous-cell delivery support system, financial system for use therewith, and method thereforHITACHI LTD·Filed 2005·Application pending·0 cites
- 2440US2019227067A1Method and kit for determining prognosis, remote recurrence risk and invasion of glioma, and pharmaceutical composition for treating gliomaUNIV SAPPORO MEDICAL·Filed 2016·Application pending·0 cites
- 2540US2022133805A1Pharmaceutical composition for treating amyotrophic lateral sclerosisUNIV SAPPORO MEDICAL·Filed 2020·Application pending·0 cites
- 2639US2022125850A1Pharmaceutical composition for preventing in-stent restenosisUNIV SAPPORO MEDICAL·Filed 2020·Application pending·0 cites
- 2736US12110480B2Observation deviceNIPRO CORP·Filed 2019·Granted Oct 8, 2024·0 cites·11 claims
- 2836US2019183937A1Life extension agentUNIV SAPPORO MEDICAL·Filed 2017·Application pending·0 cites
- 2935US2007160585A1Remedy for prion disease and method of producing the sameFUJINAGA KEI·Filed 2005·Application pending·0 cites
- 3032US2019002833A1Medicament for treating cerebral infarctionUNIV SAPPORO MEDICAL·Filed 2016·Application pending·0 cites
- 3128USD836210SCell preservation containerUNIV SAPPORO MEDICAL·Filed 2017·Granted Dec 18, 2018·1 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Osamu Honmou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →